Men receiving common medical treatments for LUTS/BPH, including phytotherapy, experienced similar symptom relief.
The risk is 67% higher in men with a prostate size of 40.1-80 mL than those with smaller glands.
A recent review found little evidence to support severe lower urinary tract symptoms as a contraindication to TRT.
Prostatic urethral lift is minimally invasive and, according to a new study, the procedure’s beneficial effects are durable out to 3 years.
Overall, men with LUTS showed remarkably poor knowledge about their symptoms.
Men who reported having severe lower urinary tract symptoms (LUTS) had a 64% increased risk of the malignancy compared with those who reported no LUTS.